GH

GUARDANT HEALTH, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

71.59
-3.14
-4.20%
Opening 14:21 09/18 EDT
OPEN
74.72
PREV CLOSE
74.73
HIGH
75.43
LOW
71.51
VOLUME
758.77K
TURNOVER
--
52 WEEK HIGH
112.22
52 WEEK LOW
27.04
MARKET CAP
5.98B
P/E (TTM)
-70.2689
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GH News

  • Zscaler stock jumps on news of partnership with CrowdStrike
  • American City Business Journals.20h ago
  • SoftBank Needs a Different IPO After WeWork Slip
  • Bloomberg.1d ago
  • Guardant Health May Be Unlikely Victim of WeWork Valuation Woes
  • Bloomberg.6d ago
  • 65 Biggest Movers From Friday
  • Benzinga.09/03 09:14

More

Industry

Biotechnology & Medical Research
-1.62%
Pharmaceuticals & Medical Research
-0.59%

Hot Stocks

Name
Price
%Change

About GH

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant360 is a molecular diagnostic test that measures 73 cancer-related genes from circulating tumor deoxyribonucleic acid (ctDNA). Its Guardant360 process includes blood collection, laboratory processing, analysis and reporting. Guardant360 is used for a range of applications, including translational science research and identifying target patient populations, drug development and commercialization post-drug approval.
More

Webull offers Guardant Health Inc (GH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.